What to know first
Most cash-pay GLP-1 programs land in the $178-$549/mo range at maintenance dose. The under-$150 tier is small and getting smaller. The injectable compounded floor sits at $178 (Mochi, flat), so anything below $150 is either an oral compounded formulation (a different product with a thinner evidence base and a lower dose ceiling) or a price that only holds with a 12-month prepay. The trade-off at this tier: less clinical support, fewer dose options, and higher regulatory exposure as state pharmacy boards tighten 503A oversight. Read the program-specific compounded-regulatory callouts before signing up.
What we considered
- All-in cash-pay monthly cost at or below $150 at maintenance dose
- Clear on whether the price is for an oral or injectable formulation
- Public disclosure of the 503A compounding pharmacy
Top pick: Strut Health

Strut Health is the only program with a true no-lock-in path at or under $150: compounded oral semaglutide from $99/mo and injectable from $149/mo, with no separate membership. The oral lozenge is a different product from the injectable most patients want, with a thinner evidence base and a lower dose ceiling, so confirm the formulation before comparing it to an injectable plan. Verify current pricing and the disclosed pharmacy partner at sign-up.
Read the full Strut Health review →
Other strong picks
